MV Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $71.9K | Buy |
1,185
+61
| +5% | +$3.56K | 0.01% | 282 |
|
|
2025
Q4 | $60.6K | Sell |
1,124
-47
| -4% | -$2.26K | 0.01% | 292 |
|
|
2025
Q3 | $52.8K | Buy |
1,171
+150
| +15% | +$7K | 0.01% | 307 |
|
|
2025
Q2 | $47.3K | Sell |
1,021
-1,622
| -61% | -$79.6K | ﹤0.01% | 312 |
|
|
2025
Q1 | $161K | Sell |
2,643
-512
| -16% | -$29.8K | 0.02% | 187 |
|
|
2024
Q4 | $178K | Buy |
3,155
+456
| +17% | +$25.5K | 0.02% | 177 |
|
|
2024
Q3 | $140K | Sell |
2,699
-231
| -8% | -$10.8K | 0.01% | 203 |
|
|
2024
Q2 | $122K | Buy |
2,930
+941
| +47% | +$42.1K | 0.01% | 204 |
|
|
2024
Q1 | $108K | Sell |
1,989
-425
| -18% | -$21.6K | 0.01% | 215 |
|
|
2023
Q4 | $124K | Buy |
2,414
+77
| +3% | +$4.04K | 0.02% | 194 |
|
|
2023
Q3 | $136K | Buy |
2,337
+184
| +9% | +$11.3K | 0.02% | 175 |
|
|
2023
Q2 | $138K | Buy |
2,153
+191
| +10% | +$12.8K | 0.02% | 178 |
|
|
2023
Q1 | $136K | Buy |
1,962
+51
| +3% | +$3.6K | 0.02% | 172 |
|
|
2022
Q4 | $137K | Buy |
1,911
+120
| +7% | +$9.05K | 0.02% | 153 |
|
|
2022
Q3 | $127K | Buy |
1,791
+336
| +23% | +$24.4K | 0.02% | 151 |
|
|
2022
Q2 | $112K | Buy |
1,455
+64
| +5% | +$4.87K | 0.02% | 159 |
|
|
2022
Q1 | $102K | Buy |
1,391
+135
| +11% | +$9.06K | 0.02% | 166 |
|
|
2021
Q4 | $78K | Buy |
1,256
+39
| +3% | +$2.29K | 0.01% | 182 |
|
|
2021
Q3 | $72K | Buy |
1,217
+96
| +9% | +$6.32K | 0.01% | 177 |
|
|
2021
Q2 | $75K | Buy |
1,121
+699
| +166% | +$45.6K | 0.01% | 169 |
|
|
2021
Q1 | $27K | Sell |
422
-1,204
| -74% | -$74.9K | ﹤0.01% | 201 |
|
|
2020
Q4 | $101K | Hold |
1,626
| – | – | 0.02% | 133 |
|
|
2020
Q3 | $98K | Hold |
1,626
| – | – | 0.02% | 128 |
|
|
2020
Q2 | $96K | Hold |
1,626
| – | – | 0.02% | 125 |
|
|
2020
Q1 | $91K | Buy |
1,626
+38
| +2% | +$2.32K | 0.02% | 127 |
|
|
2019
Q4 | $102K | Sell |
1,588
-57
| -3% | -$3.26K | 0.02% | 137 |
|
|
2019
Q3 | $83K | Buy |
1,645
+1,379
| +518% | +$64.8K | 0.02% | 140 |
|
|
2019
Q2 | $12K | Hold |
266
| – | – | ﹤0.01% | 221 |
|
|
2019
Q1 | $13K | Sell |
266
-64
| -19% | -$3.19K | ﹤0.01% | 211 |
|
|
2018
Q4 | $17K | Sell |
330
-750
| -69% | -$40.3K | ﹤0.01% | 199 |
|
|
2018
Q3 | $67K | Hold |
1,080
| – | – | 0.02% | 151 |
|
|
2018
Q2 | $60K | Hold |
1,080
| – | – | 0.02% | 157 |
|
|
2018
Q1 | $68K | Buy |
1,080
+750
| +227% | +$48.2K | 0.02% | 151 |
|
|
2017
Q4 | $20K | Hold |
330
| – | – | 0.01% | 206 |
|
|
2017
Q3 | $21K | Sell |
330
-400
| -55% | -$23.4K | 0.01% | 197 |
|
|
2017
Q2 | $41K | Sell |
730
-11
| -1% | -$599 | 0.01% | 164 |
|
|
2017
Q1 | $40K | Hold |
741
| – | – | 0.01% | 169 |
|
|
2016
Q4 | $43K | Hold |
741
| – | – | 0.02% | 161 |
|
|
2016
Q3 | $40K | Hold |
741
| – | – | 0.01% | 159 |
|
|
2016
Q2 | $55K | Hold |
741
| – | – | 0.02% | 150 |
|
|
2016
Q1 | $47K | Hold |
741
| – | – | 0.02% | 153 |
|
|
2015
Q4 | $51K | Buy |
741
+400
| +117% | +$26.4K | 0.02% | 157 |
|
|
2015
Q3 | $20K | Sell |
341
-165
| -33% | -$10.5K | 0.01% | 192 |
|
|
2015
Q2 | $34K | Hold |
506
| – | – | 0.01% | 203 |
|
|
2015
Q1 | $33K | Sell |
506
-42
| -8% | -$2.63K | 0.01% | 192 |
|
|
2014
Q4 | $32K | Buy |
+548
| New | +$30.9K | 0.01% | 191 |
|
Other funds holding BMY
VCM
VPM
MV Capital Management's BMY Position: Q1 2026 in Review
MV Capital Management increased its Bristol-Myers Squibb (BMY) stake by 5.4% in Q1 2026, buying an estimated $3.56K and bringing the position to 1,185 shares worth $71.9K. The position accounts for 0.01% of the portfolio, ranked #282.
MV Capital Management first reported a position in BMY in Q4 2014 and has held it in 46 quarters since. The position peaked at $178K in Q4 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- MV Capital Management held 1,185 shares of Bristol-Myers Squibb worth $71.9K as of Q1 2026.
- MV Capital Management bought 61 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.56K.
- Bristol-Myers Squibb made up 0.01% of MV Capital Management's portfolio in Q1 2026, its #282 holding.
- MV Capital Management first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 46 quarters since.
- MV Capital Management's Bristol-Myers Squibb position peaked at $178K in Q4 2024.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on MV Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.